|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.34 USD | -1.31% |
|
-2.54% | -36.71% |
| 11-25 | Healthcare Stocks Gain Ground -- Healthcare Roundup | DJ |
| 11-24 | Americans waiting for Obamacare subsidies delay or drop health insurance | RE |
| Capitalization | 18.84B 16.2B 15.17B 14.14B 26.12B 1,696B 28.42B 177B 68.53B 801B 70.73B 69.22B 2,929B | P/E ratio 2025 * |
-3.79x | P/E ratio 2026 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise value | 22.16B 19.05B 17.84B 16.63B 30.72B 1,994B 33.41B 209B 80.58B 942B 83.16B 81.39B 3,444B | EV / Sales 2025 * |
0.11x | EV / Sales 2026 * | 0.11x |
| Free-Float |
79.74% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Centene Corporation
| 1 day | -1.31% | ||
| 1 week | -2.54% | ||
| Current month | -2.54% | ||
| 1 month | +3.34% | ||
| 3 months | +32.30% | ||
| 6 months | -30.49% | ||
| Current year | -36.71% |
| 1 week | 37.41 | 39.34 | |
| 1 month | 33.61 | 39.93 | |
| Current year | 25.08 | 66.81 | |
| 1 year | 25.08 | 66.81 | |
| 3 years | 25.08 | 87.79 | |
| 5 years | 25.08 | 98.53 | |
| 10 years | 23.68 | 98.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah London
CEO | Chief Executive Officer | 44 | 22/03/2022 |
Drew Asher
DFI | Director of Finance/CFO | 56 | 07/05/2021 |
Susan Smith
COO | Chief Operating Officer | 49 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 31/03/2023 | |
Jessica Blume
BRD | Director/Board Member | 70 | 05/02/2018 |
H. Dallas
CHM | Chairman | 66 | 23/02/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.31% | -2.54% | -32.45% | -55.38% | 18.84B | ||
| -0.77% | +0.35% | -39.79% | -38.64% | 300B | ||
| -0.31% | -2.22% | -13.45% | -37.41% | 73.51B | ||
| -1.11% | -4.27% | -16.48% | -19.48% | 70.91B | ||
| +1.91% | +4.92% | -8.48% | -52.80% | 31.01B | ||
| +0.86% | +2.43% | -48.52% | -54.75% | 7.81B | ||
| +0.77% | +1.77% | +71.64% | +60.38% | 3.91B | ||
| -0.54% | -8.91% | +62.74% | -24.89% | 2.07B | ||
| -3.01% | +3.61% | -23.21% | +116.81% | 1.33B | ||
| -0.17% | -1.03% | -21.87% | - | 388M | ||
| Average | -0.37% | -0.70% | -6.99% | -11.80% | 50.95B | |
| Weighted average by Cap. | -0.58% | -0.48% | -29.37% | -36.30% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 193B 166B 155B 145B 267B 17,359B 291B 1,817B 701B 8,198B 724B 708B 29,976B | 193B 166B 156B 145B 268B 17,385B 291B 1,819B 703B 8,211B 725B 710B 30,022B |
| Net income | -3.62B -3.11B -2.92B -2.72B -5.02B -326B -5.46B -34.11B -13.17B -154B -13.59B -13.3B -563B | 890M 765M 717M 668M 1.23B 80.1B 1.34B 8.38B 3.24B 37.83B 3.34B 3.27B 138B |
| Net Debt | 3.31B 2.85B 2.67B 2.49B 4.59B 298B 4.99B 31.2B 12.05B 141B 12.43B 12.17B 515B | 1.87B 1.61B 1.5B 1.4B 2.59B 168B 2.82B 17.6B 6.79B 79.41B 7.01B 6.86B 290B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 38.34 $ | -1.31% | 7,470,563 |
| 04/12/25 | 38.85 $ | +0.10% | 4,798,315 |
| 03/12/25 | 38.81 $ | 0.00% | 3,838,195 |
| 02/12/25 | 38.81 $ | +2.43% | 7,406,905 |
| 01/12/25 | 37.89 $ | -3.69% | 6,429,875 |
Delayed Quote Nyse, December 06, 2025 at 01:00 am
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CNC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















